Orchid Bioventures is Biotechnology in United States that focus on developer business. Founded in 2020. They cover business area such as developer, biotechnology, pharmaceutical, firm, development-stage life science company, investor, necessary resource, every step, their life cycle, discipline, corporate development, technology sourcing, acquisition, licensing, financing support, M&A, their scientific idea, reality, product, patient.
2020
( 4 years old in 2024 )
Developer
-
2275 Research Boulevard
Suite 500
Rockville, MD 20850
United States
Private
developerbiotechnologypharmaceuticalfirmdevelopment-stage life science companyinvestornecessary resourceevery steptheir life cycledisciplinecorporate developmenttechnology sourcingacquisitionlicensingfinancing supportM&Atheir scientific idearealityproductpatient
* We use standard office opening hours in near Orchid Bioventures's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Orchid Bioventures is Biotechnology business from United States that founded in 2020 (4 years old in 2024), Orchid Bioventures business is focusing on Developer.
Orchid Bioventures headquarter office and corporate office address is located in 2275 Research Boulevard Suite 500 Rockville, MD 20850 United States.
Orchid Bioventures was founded in United States.
In 2024, Orchid Bioventures is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Orchid Bioventures, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
